metaphactory is used by this German pharmaceutical company to power a Knowledge Graph-based R&D Explorer providing actionable insights for target and drug discovery and drug safety reporting. The R&D Exoplorer offers a unified information hub for proprietary and publicly available research data related to performed clinical studies, reported adverse events, drug and substance data, molecular data, and information on indications. It supports researchers in their drug discovery processes by allowing them to connect the dots between these disparate pieces of information, perform similarity matches between indications, studies and subjects, and exploratively investigate interesting targets.
R&D explorer, Drug development & drug repurposing, Drug safety reviews, Target discovery
Knowledge graph exploration, Knowledge Democratization